<tt id="msi8q"></tt>
  • <nav id="msi8q"><strong id="msi8q"></strong></nav><menu id="msi8q"><menu id="msi8q"></menu></menu>
  • <menu id="msi8q"><menu id="msi8q"></menu></menu>
    <nav id="msi8q"><code id="msi8q"></code></nav><menu id="msi8q"></menu>
    ?

    About Us


    MaxiNovel Pharmaceuticals Co.,Ltd. is a China based biotech company founded in 2016 to focus on the innovative drug research with the global intellectual property rights.

    We carry out first-in-class small molecule drug discovery in the areas of targeted therapy and immunotherapy. Our rapidly expanding product pipeline is mainly composed of programs that target both blood tumors and solid tumors as well as autoimmune diseases. Company’s research platforms encompass oral therapy, radiotherapy, imaging and transdermal therapy.

    We have our R&D and operation centers in China (Shanghai, Guangzhou, Shenzhen), the United States and Australia.  Our management team members all have extensive previous working experiences in global pharmaceutical companies and capital markets, more importantly global vision of our company’s future development.

    Our mission is to conduct pharmaceutical innovation to save lives and bring hopes to patients and their families.



    Pipeline

    • Items
    • Preclinical
    • Phase I
    • Phase II
    • Phase Ⅲ
    • MAX-4

      Targeted Therapy
      AML

    • MAX-5

      Targeted Therapy
      Solid tumors

    • MAX-1

      IO Therapy
      Solid tumors

    • MAX-3

      Alopecia Areata
      Atopic Dermatitis

    • MAX-2

      Imaging
      Solid tumors

    • MAX-8

      Radio-Ligand
      Therapy

    • MAX-7

      Solid tumors

    • MAX-6

      IPF

    • MAX-9

      Alopecia

    • MAX-10

      Psoriasis

    Click Show

    News

    All News
    ? 男人av在线,377p亚洲欧洲日本大胆色噜噜,国产白丝无码视频在线观看免费,性饥渴的少妇AV无码,日韩乱码人妻无码中文字幕免费,又大又深又爽高潮视频